The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Positron Emission Tomography (PET) in Oncology
Open accessAbstract
Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment during or after treatment end and radiotherapy planning. Moreover, the continuous technological progress of image generation and the introduction of sophisticated software to use PET scan as a biomarker paved the way to calculate new prognostic markers such as the metabolic tumor volume (MTV) and the total amount of tumor glycolysis (TLG). FDG-PET/CT proved more sensitive than contrast-enhanced CT scan in staging of several type of lymphoma or in detecting widespread tumor dissemination in several solid cancers, such as breast, lung, colon, ovary and head and neck carcinoma. As a consequence the stage of patients was upgraded, with a change of treatment in 10%–15% of them. One of the most evident advantages of FDG-PET was its ability to detect, very early during treatment, significant changes in glucose metabolism or even complete shutoff of the neoplastic cell metabolism as a surrogate of tumor chemosensitivity assessment. This could enable clinicians to detect much earlier the effectiveness of a given antineoplastic treatment, as compared to the traditional radiological detection of tumor shrinkage, which usually takes time and occurs much later.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Appio, L., Landoni, C., La Targia, M., Bertolli, V., Chiarucci, M., Crovetti, G., Vassenna, E., Serio, G., & Bregni, M. (2017) · Chemotherapy · doi:10.1159/000458147 · Cited by 2,327
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2672 · Cited by 2,165
Mandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
Lyman, G. H., Giuliano, A. E., Somerfield, M. R., Benson, A. B., Bodurka, D. C., Burstein, H. J., Cochran, A. J., Cody, H. S., Edge, S. B., Galper, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.001 · Cited by 1,887
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,200
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
Kyle, R. A., & Rajkumar, S. V. (2009) · Leukemia · doi:10.1038/leu.2008.291 · Cited by 1,121
Ledermann, J. A., Raja, F. A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt333 · Cited by 1,104
Recommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Gould, M. K., Maclean, C. C., Kuschner, W. G., Rydzak, C. E., & Owens, D. K. (2001) · JAMA · doi:10.1001/jama.285.7.914 · Cited by 1,094
Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., Rotman, M., Gershenson, D., & Mutch, D. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.197 · Cited by 1,018
Bipat, S., Glas, A. S., Slors, F. J. M., Zwinderman, A. H., Bossuyt, P. M. M., & Stoker, J. (2004) · Radiology · doi:10.1148/radiol.2323031368 · Cited by 1,015
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Center, M. M., Ward, E., Wu, X.-C., Eheman, C., Anderson, R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 957
Bear, H. D., Anderson, S., Smith, R. E., Geyer, C. E., Mamounas, E. P., Fisher, B., Brown, A. M., Robidoux, A., Margolese, R., Kahlenberg, M. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1665 · Cited by 943
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee
Berland, L. L., Silverman, S. G., Gore, R. M., Mayo-Smith, W. W., Megibow, A. J., Yee, J., Brink, J. A., Baker, M. E., Federle, M. P., Foley, W. D., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2010.06.013 · Cited by 868
Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Self-citationThe applications of PET in clinical oncology.
Strauss, L. G., & Conti, P. S. (1991) · PubMed · Cited by 844
Lordick, F., Ott, K., Krause, B.-J., Weber, W. A., Becker, K., Stein, H. J., Lorenzen, S., Schuster, T., Wieder, H., Herrmann, K., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70244-9 · Cited by 804
SUV: standard uptake or silly useless value?
Keyes, J. W. (1995) · PubMed · Cited by 803
Report on the First International Workshop on interim-PET scan in lymphoma
Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009) · Leukemia & Lymphoma · doi:10.1080/10428190903040048 · Cited by 754
Self-citationHutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Daisne, J.-F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., & Grégoire, V. (2004) · Radiology · doi:10.1148/radiol.2331030660 · Cited by 677
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
Zasadny, K. R., & Wahl, R. L. (1993) · Radiology · doi:10.1148/radiology.189.3.8234714 · Cited by 635
Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Larson, S. (1999) · Clinical Positron Imaging · doi:10.1016/s1095-0397(99)00016-3 · Cited by 598
Niekel, M. C., Bipat, S., & Stoker, J. (2010) · Radiology · doi:10.1148/radiol.10100729 · Cited by 584
Preoperative Staging of Lung Cancer with Combined PET–CT
Fischer, B., Lassen, U., Mortensen, J., Larsen, S., Loft, A., Bertelsen, A., Ravn, J., Clementsen, P., Høgholm, A., Larsen, K., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900043 · Cited by 582
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Bonadonna, G., Valagussa, P., Brambilla, C., Ferrari, L., Moliterni, A., Terenziani, M., & Zambetti, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.93 · Cited by 566
Prognostic Factors in Non-small Cell Lung Cancer
Brundage, M. D., Davies, D., & Mackillop, W. J. (2002) · Chest · doi:10.1378/chest.122.3.1037 · Cited by 564
Prospective investigation of positron emission tomography in lung nodules.
Lowe, V. J., Fletcher, J. W., Gobar, L., Lawson, M., Kirchner, P., Valk, P., Karis, J., Hubner, K., Delbeke, D., Heiberg, E. V., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1075 · Cited by 552
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Någren, K., Darcourt, J., Kapucu, Ö. L., Tatsch, K., Bartenstein, P., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1264-0 · Cited by 544
Zamagni, E., Patriarca, F., Nanni, C., Zannetti, B., Englaro, E., Pezzi, A., Tacchetti, P., Buttignol, S., Perrone, G., Brioli, A., et al. (2011) · Blood · doi:10.1182/blood-2011-06-361386 · Cited by 531
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Staging investigations for oesophageal cancer: a meta-analysis
van Vliet, E. P. M., Heijenbrok-Kal, M. H., Hunink, M. G. M., Kuipers, E. J., & Siersema, P. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604200 · Cited by 517
Drzezga, A., Souvatzoglou, M., Eiber, M., Beer, A. J., Fürst, S., Martinez-Möller, A., Nekolla, S. G., Ziegler, S., Ganter, C., Rummeny, E. J., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098608 · Cited by 508
Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?
Gould, M. K., Fletcher, J., Iannettoni, M. D., Lynch, W. R., Midthun, D. E., Naidich, D. P., & Ost, D. E. (2007) · Chest · doi:10.1378/chest.07-1353 · Cited by 503
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding
Erdi, Y. E., Mawlawi, O., Larson, S. M., Imbriaco, M., Yeung, H., Finn, R., & Humm, J. L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12+<2505::aid-cncr24>3.0.co;2-f · Cited by 480
Shim, S. S., Lee, K. S., Kim, B.-T., Chung, M. J., Lee, E. J., Han, J., Choi, J. Y., Kwon, O. J., Shim, Y. M., & Kim, S. (2005) · Radiology · doi:10.1148/radiol.2363041310 · Cited by 444
Mac Manus, M. P., Hicks, R. J., Matthews, J. P., McKenzie, A., Rischin, D., Salminen, E. K., & Ball, D. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.054 · Cited by 439
Forner, A., Ayuso, C., Varela, M., Rimola, J., Hessheimer, A. J., de Lope, C. R., Reig, M., Bianchi, L., Llovet, J. M., & Bruix, J. (2009) · Cancer · doi:10.1002/cncr.24050 · Cited by 426
A gradient-based method for segmenting FDG-PET images: methodology and validation
Geets, X., Lee, J. A., Bol, A., Lonneux, M., & Grégoire, V. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0363-4 · Cited by 419
Fisher, E. R., Wang, J., Bryant, J., Fisher, B., Mamounas, E., & Wolmark, N. (2002) · Cancer · doi:10.1002/cncr.10741 · Cited by 413
Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1676 · Cited by 406
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Gralow, J. R., Burstein, H. J., Wood, W., Hortobagyi, G. N., Gianni, L., von Minckwitz, G., Buzdar, A. U., Smith, I. E., Symmans, W. F., Singh, B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.3510 · Cited by 400
Boellaard, R., Oyen, W. J. G., Hoekstra, C. J., Hoekstra, O. S., Visser, E. P., Willemsen, A. T., Arends, B., Verzijlbergen, F. J., Zijlstra, J., Paans, A. M., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0874-2 · Cited by 396
Lin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042093 · Cited by 394
Groheux, D., Giacchetti, S., Moretti, J.-L., Porcher, R., Espié, M., Lehmann-Che, J., de Roquancourt, A., Hamy, A.-S., Cuvier, C., Vercellino, L., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1640-9 · Cited by 394
Brücher, B. L. D. M., Weber, W., Bauer, M., Fink, U., Avril, N., Stein, H. J., Werner, M., Zimmerman, F., Siewert, J. R., & Schwaiger, M. (2001) · Annals of Surgery · doi:10.1097/00000658-200103000-00002 · Cited by 389
Daisne, J.-F., Sibomana, M., Bol, A., Doumont, T., Lonneux, M., & Grégoire, V. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00270-6 · Cited by 380
Adams, K., Shah, P. L., Edmonds, L., & Lim, E. (2009) · Thorax · doi:10.1136/thx.2008.109868 · Cited by 370
Zaidi, H., & El Naqa, I. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1423-3 · Cited by 366
Umbehr, M. H., Müntener, M., Hany, T., Sulser, T., & Bachmann, L. M. (2013) · European Urology · doi:10.1016/j.eururo.2013.04.019 · Cited by 354
Barrington, S. F., Qian, W., Somer, E. J., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Højgaard, L., Federico, M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1490-5 · Cited by 348
Self-citationGurney, J. W. (1993) · Radiology · doi:10.1148/radiology.186.2.8421743 · Cited by 343
Erasmus, J. J., Patz, E. F., McAdams, H. P., Murray, J. G., Herndon, J., Coleman, R. E., & Goodman, P. C. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.5.9129444 · Cited by 333
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
Hutchings, M., Mikhaeel, N. G., Fields, P. A., Nunan, T., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi200 · Cited by 327
Moskowitz, C. H., Schöder, H., Teruya-Feldstein, J., Sima, C., Iasonos, A., Portlock, C. S., Straus, D., Noy, A., Palomba, M. L., O'Connor, O. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5942 · Cited by 326
Sharma, R. A., Hazel, G. A. V., Morgan, B., Berry, D. P., Blanshard, K., Price, D., Bower, G., Shannon, J. A., Gibbs, P., & Steward, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7916 · Cited by 323
Stahl, A., Ott, K., Weber, W., Becker, K., Link, T., Siewert, J.-R., Schwaiger, M., & Fink, U. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1029-5 · Cited by 321
Imaging of Cell Proliferation: Status and Prospects
Bading, J. R., & Shields, A. F. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046391 · Cited by 320
Sironi, S., Buda, A., Picchio, M., Perego, P., Moreni, R., Pellegrino, A., Colombo, M., Mangioni, C., Messa, C., & Fazio, F. (2006) · Radiology · doi:10.1148/radiol.2381041799 · Cited by 315
Gallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., Iannitto, E., et al. (2006) · PubMed · Cited by 314
Self-citationBiggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., Meignan, M., Malkowski, B., Hofman, M. S., & Barrington, S. F. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110890 · Cited by 311
Self-citationDurie, B. G. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.037 · Cited by 300
El-Galaly, T. C., d'Amore, F., Mylam, K. J., de Nully Brown, P., Bøgsted, M., Bukh, A., Specht, L., Loft, A., Iyer, V., Hjorthaug, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4036 · Cited by 295
The Lessons of GIST—PET and PET/CT: A New Paradigm for Imaging
Van den Abbeele, A. D. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s2-8 · Cited by 292
Role of Functional Imaging in the Management of Lymphoma
Cheson, B. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5225 · Cited by 280
Evangelista, L., Zattoni, F., Guttilla, A., Saladini, G., Zattoni, F., Colletti, P. M., & Rubello, D. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182867f3c · Cited by 278
Evangelista, L., Guttilla, A., Zattoni, F., Muzzio, P. C., & Zattoni, F. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.039 · Cited by 278
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Costelloe, C. M., Chuang, H. H., Madewell, J. E., & Ueno, N. T. (2010) · Journal of Cancer · doi:10.7150/jca.1.80 · Cited by 270
Assessing Tumor Response to Therapy
Weber, W. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057174 · Cited by 269
Accuracy of PET/CT in characterization of solitary pulmonary lesions.
Kim, S. K., Allen-Auerbach, M., Goldin, J. G., Fueger, B. J., Dahlbom, M. L., Brown, M. S., Czernin, J. G., & Schiepers, C. W. (2007) · PubMed · Cited by 267
Effectiveness of Positron Emission Tomography for the Detection of Melanoma Metastases
Holder, W. D., White, R. L., Zuger, J. H., Easton, E. J., & Greene, F. L. (1998) · Annals of Surgery · doi:10.1097/00000658-199805000-00017 · Cited by 264
Imaging in staging of malignant lymphoma: a systematic review
Kwee, T. C., Kwee, R. M., & Nievelstein, R. A. J. (2008) · Blood · doi:10.1182/blood-2007-07-101899 · Cited by 264
Chollet, P., Amat, S., Cure, H., de Latour, M., Le Bouedec, G., Mouret-Reynier, M.-A., Ferriere, J.-P., Achard, J.-L., Dauplat, J., & Penault-Llorca, F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600210 · Cited by 259
The effect of measuring error on the results of therapeutic trials in advanced cancer
Moertel, C. G., & Hanley, J. A. (1976) · Cancer · doi:10.1002/1097-0142(197607)38:1<388::aid-cncr2820380156>3.0.co;2-a · Cited by 257
Gallamini, A., Barrington, S. F., Biggi, A., Chauvie, S., Kostakoglu, L., Gregianin, M., Meignan, M., Mikhaeel, G. N., Loft, A., Zaucha, J. M., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.103218 · Cited by 254
Self-citationTerasawa, T., Lau, J., Bardet, S., Couturier, O., Hotta, T., Hutchings, M., Nihashi, T., & Nagai, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0861 · Cited by 254
FDG-PET for management of cervical and ovarian cancer
Havrilesky, L. J., Kulasingam, S. L., Matchar, D. B., & Myers, E. R. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.007 · Cited by 253
Hofman, M. S., Kong, G., Neels, O. C., Eu, P., Hong, E., & Hicks, R. J. (2012) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2011.02327.x · Cited by 251
Hoekstra, C. J., Paglianiti, I., Hoekstra, O. S., Smit, E. F., Postmus, P. E., Teule, G. J. J., & Lammertsma, A. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050570 · Cited by 251
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Khan, A. B., Barrington, S. F., Mikhaeel, N. G., Hunt, A. A., Cameron, L., Morris, T., & Carr, R. (2013) · Blood · doi:10.1182/blood-2012-12-473389 · Cited by 246
From PET detectors to PET scanners
Humm, J. L., Rosenfeld, A., & Del Guerra, A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1266-2 · Cited by 245
Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion
Riegel, A. C., Berson, A. M., Destian, S., Ng, T., Tena, L. B., Mitnick, R. J., & Wong, P. S. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.014 · Cited by 242
Pregno, P., Chiappella, A., Bellò, M., Botto, B., Ferrero, S., Franceschetti, S., Giunta, F., Ladetto, M., Limerutti, G., Menga, M., et al. (2012) · Blood · doi:10.1182/blood-2011-06-359943 · Cited by 236
Rinne, D., Baum, R. P., Hör, G., & Kaufmann, R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980501)82:9<1664::aid-cncr11>3.0.co;2-2 · Cited by 225
Residual mass in lymphoma may not be residual disease.
Canellos, G. P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.6.931 · Cited by 220
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers
Facey, K., Bradbury, I., Laking, G., & Payne, E. (2007) · Health Technology Assessment · doi:10.3310/hta11440 · Cited by 219
Dibble, E. H., Lara Alvarez, A. C., Truong, M.-T., Mercier, G., Cook, E. F., & Subramaniam, R. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.099531 · Cited by 217
Werner-Wasik, M., Nelson, A. D., Choi, W., Arai, Y., Faulhaber, P. F., Kang, P., Almeida, F. D., Xiao, Y., Ohri, N., Brockway, K. D., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.055 · Cited by 214
Naumann, R., Vaic, A., Beuthien‐Baumann, B., Bredow, J., Kropp, J., Kittner, T., Franke, W., & Ehninger, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03147.x · Cited by 212
Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma
Wong, R. K., Tandan, V., De Silva, S., & Figueredo, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002102.pub2 · Cited by 212
Schwarz-Dose, J., Untch, M., Tiling, R., Sassen, S., Mahner, S., Kahlert, S., Harbeck, N., Lebeau, A., Brenner, W., Schwaiger, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2650 · Cited by 211
Schinagl, D. A. X., Vogel, W. V., Hoffmann, A. L., van Dalen, J. A., Oyen, W. J., & Kaanders, J. H. A. M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.07.2333 · Cited by 211
de Geus-Oei, L.-F., Vriens, D., van Laarhoven, H. W. M., van der Graaf, W. T. A., & Oyen, W. J. G. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057224 · Cited by 207
Research Reporting Standards for Radioembolization of Hepatic Malignancies
Salem, R., Lewandowski, R. J., Gates, V. L., Nutting, C. W., Murthy, R., Rose, S. C., Soulen, M. C., Geschwind, J.-F. H., Kulik, L., Kim, Y. H., et al. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.10.029 · Cited by 200
Gouy, S., Morice, P., Narducci, F., Uzan, C., Martinez, A., Rey, A., Bentivegna, E., Pautier, P., Deandreis, D., Querleu, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3520 · Cited by 200
Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres
Lhommel, R., van Elmbt, L., Goffette, P., Van den Eynde, M., Jamar, F., Pauwels, S., & Walrand, S. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1470-9 · Cited by 198
Rieber, A., Nüssle, K., Stöhr, I., Grab, D., Fenchel, S., Kreienberg, R., Reske, S. N., & Brambs, H. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.1.1770123 · Cited by 196
Castellucci, P., Perrone, A. M., Picchio, M., Ghi, T., Farsad, M., Nanni, C., Messa, C., Meriggiola, M. C., Pelusi, G., Al-Nahhas, A., et al. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3281afa256 · Cited by 192
Measuring response in a post-RECIST world: from black and white to shades of grey
Michaelis, L. C., & Ratain, M. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1883 · Cited by 192
Dupuis, J., Berriolo-Riedinger, A., Julian, A., Brice, P., Tychyj-Pinel, C., Tilly, H., Mounier, N., Gallamini, A., Feugier, P., Soubeyran, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0934 · Cited by 191
Self-citationMetabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer
Lee, P., Weerasuriya, D. K., Lavori, P. W., Quon, A., Hara, W., Maxim, P. G., Le, Q.-T., Wakelee, H. A., Donington, J. S., Graves, E. E., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.036 · Cited by 191
A novel fuzzy C‐means algorithm for unsupervised heterogeneous tumor quantification in PET
Belhassen, S., & Zaidi, H. (2010) · Medical Physics · doi:10.1118/1.3301610 · Cited by 190
De Wever, W., Ceyssens, S., Mortelmans, L., Stroobants, S., Marchal, G., Bogaert, J., & Verschakelen, J. A. (2007) · European Radiology · doi:10.1007/s00330-006-0284-4 · Cited by 188
Billé, A., Pelosi, E., Skanjeti, A., Arena, V., Errico, L., Borasio, P., Mancini, M., & Ardissone, F. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.04.003 · Cited by 186
Yu, H., Caldwell, C., Mah, K., & Mozeg, D. (2009) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2008.2004425 · Cited by 184
Colombo, N., Peiretti, M., Parma, G., Lapresa, M., Mancari, R., Carinelli, S., Sessa, C., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq244 · Cited by 184
Spence, A. M., Muzi, M., Mankoff, D. A., O’Sullivan, S., Link, J. M., Lewellen, T. K., Lewellen, B., Pham, P., Minoshima, S., Swanson, K. R., et al. (2004) · PubMed · Cited by 182
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
Isasi, C. R., Moadel, R. M., & Blaufox, M. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-3291-7 · Cited by 181
Surbone, A., Longo, D. L., DeVita, V. T., Ihde, D. C., Duffey, P. L., Jaffe, E. S., Solomon, D., Hubbard, S. M., & Young, R. C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1832 · Cited by 180
Karrison, T. G., Maitland, M. L., Stadler, W. M., & Ratain, M. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm158 · Cited by 177
Kekelidze, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8502 · Cited by 176
Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancer
von Eyben, F. E., & Kairemo, K. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000040 · Cited by 171
Du, Y., Cullum, I., Illidge, T., & Ell, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2854 · Cited by 171
Kostakoglu, L., Goldsmith, S. J., Leonard, J. P., Christos, P., Furman, R. R., Atasever, T., Chandramouly, A., Verma, S., Kothari, P., & Coleman, M. (2006) · Cancer · doi:10.1002/cncr.22276 · Cited by 168
Is there still a role for SPECT–CT in oncology in the PET–CT era?
Hicks, R. J., & Hofman, M. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.188 · Cited by 165
Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
Marcus, C. S., Maxwell, G. L., Darcy, K. M., Hamilton, C. A., & McGuire, W. P. (2014) · Journal of Cancer · doi:10.7150/jca.7810 · Cited by 165
Brush, J. P., Boyd, K., Chappell, F. M., Crawford, F., Dozier, M., Fenwick, E. A. L., Glanville, J., McIntosh, H., Renehan, A. G., Weller, D., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15350 · Cited by 162
Selwyn, R. G., Nickles, R. J., Thomadsen, B., DeWerd, L. A., & Micka, J. A. (2006) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2006.08.009 · Cited by 160
Chung, H. H., Kwon, H. W., Kang, K. W., Park, N.-H., Song, Y. S., Chung, J.-K., Kang, S., & Kim, J. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2153-x · Cited by 160
Van de Wiele, C., Kruse, V., Smeets, P., Sathekge, M., & Maes, A. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2280-z · Cited by 159
Fueger, B. J., Czernin, J., Cloughesy, T., Silverman, D. H., Geist, C. L., Walter, M. A., Schiepers, C., Nghiemphu, P., Lai, A., Phelps, M. E., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.078592 · Cited by 159
Cerci, J. J., Pracchia, L. F., Linardi, C. C. G., Pitella, F. A., Delbeke, D., Izaki, M., Trindade, E. M., Soares, J., Buccheri, V., & Meneghetti, J. C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073197 · Cited by 157
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis
Wang, Z., Chen, J.-Q., Liu, J., Qin, X., & Huang, Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i29.4808 · Cited by 157
Wright, G. M. (2006) · Thorax · doi:10.1136/thx.2005.051995 · Cited by 157
Vansteenkiste, J., Stroobants, S. G., Leyn, P. R. D., Dupont, P. J., & Verbeken, E. K. (1998) · Annals of Oncology · doi:10.1023/a:1008437915860 · Cited by 155
Schaefer, A., Kremp, S., Hellwig, D., Rübe, C., Kirsch, C., & Nestle, U. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0875-1 · Cited by 154
Bryant, A., Cerfolio, R., Klemm, K., & Ojha, B. C. (2006) · Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.12.047 · Cited by 154
Cashen, A. F., Dehdashti, F., Luo, J. R., Homb, A. C., Siegel, B. A., & Bartlett, N. L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082586 · Cited by 153
Donckier, V., Laethem, J. V., Goldman, S., Gansbeke, D. V., Feron, P., Ickx, B., Wikler, D., & Gelin, M. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10314 · Cited by 150
Connell, C. A., Corry, J. F., Milner, A. D., Hogg, A., Hicks, R. J., Rischin, D., & Peters, L. J. (2007) · Head & Neck · doi:10.1002/hed.20629 · Cited by 150
Langenhoff, B. S., Oyen, W. J. G., Jager, G. J., Strijk, S. P., Wobbes, T., Corstens, F. H. M., & Ruers, T. J. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.134 · Cited by 149
Predictive and prognostic value of FDG‐PET in nonsmall‐cell lung cancer: A systematic review
de Geus‐Oei, L., van der Heijden, E. H. F. M., Corstens, F. H. M., & Oyen, W. J. G. (2007) · Cancer · doi:10.1002/cncr.22979 · Cited by 147
Lutz, M. P., Zalcberg, J. R., Ducreux, M. P., Ajani, J. A., Allum, W., Aust, D., Bang, Y., Cascinu, S., Hölscher, A. H., Jankowski, J. A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.029 · Cited by 146
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
Dortz, L. L., de Guibert, S., Bayat, S., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1539-5 · Cited by 145
False-Positive Lesions Mimicking Breast Cancer on FDG PET and PET/CT
Adejolu, M., Huo, L., ROHREN, E. M., Santiago, L., & Yang, W. T. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7130 · Cited by 142
Minn, H. R. I., Paul, R., & Ahonen, A. K. (1988) · PubMed · Cited by 142
Tylski, P., Stute, S., Grotus, N., Doyeux, K., Hapdey, S., Gardin, I., Vanderlinden, B., & Buvat, I. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066241 · Cited by 141
Lizárraga, K. J., Allen-Auerbach, M., Czernin, J. G., DeSalles, A. A. F., Yong, W. H., Phelps, M. E., & Chen, W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121418 · Cited by 140
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
Tatsumi, M., Cohade, C., Nakamoto, Y., Fishman, E. K., & Wahl, R. L. (2005) · Radiology · doi:10.1148/radiol.2373040555 · Cited by 138
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.
Hoekstra, C. J., Hoekstra, O. S., Stroobants, S. G., Vansteenkiste, J., Nuyts, J. L., Smit, E. F., Boers, M., Twisk, J. W. R., & Lammertsma, A. A. (2002) · PubMed · Cited by 136
Meignan, M. A., Gallamini, A., Haïoun, C., & Polliack, A. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.529208 · Cited by 134
Self-citationRodríguez‐Vigil, B., León, N. G., Pinilla, I., Hernández‐Maraver, D., Coya, J., Curto, L. M. M., & Madero, R. (2006) · PubMed · Cited by 133
Xu, G., Guan, D.-J., & He, Z. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.04.021 · Cited by 133
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
Kratochwil, C., Combs, S. E., Leotta, K., Afshar-Oromieh, A., Rieken, S., Debus, J., Haberkorn, U., & Giesel, F. L. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not199 · Cited by 133
Veit, P., Antoch, G., Stergar, H., Bockisch, A., Forsting, M., & Kuehl, H. (2005) · European Radiology · doi:10.1007/s00330-005-2767-0 · Cited by 133
Resection for Esophageal Cancer: Strategies for Optimal Management
Pennathur, A., & Luketich, J. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.11.078 · Cited by 131
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Ambrosini, V., Campana, D., Tomassetti, P., & Fanti, S. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1989-4 · Cited by 130
A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours
Li, H., Thorstad, W. L., Biehl, K. J., Laforest, R. A., Su, Y., Shoghi, K. I., Donnelly, E. D., Low, D. A., & Lü, W. (2008) · Medical Physics · doi:10.1118/1.2956713 · Cited by 129
PET and PET/CT in Pediatric Oncology
Jadvar, H., Connolly, L. P., Fahey, F. H., & Shulkin, B. L. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.04.001 · Cited by 127
Wust, P., Amthauer, H., Denecke, T., Rau, B., Ruf, J., Schneider, U., H�nerbein, M., Gutberlet, M., Schlag, P. M., Felix, R., et al. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1453-1 · Cited by 126
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer
Sobhani, I., Tiret, E., Lebtahi, R., Aparicio, T., Itti, E., Montravers, F., de Labriolle-Vaylet, C., Rougier, P. R., André, T., Gornet, J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604263 · Cited by 123
Concurrent multimodality image segmentation by active contours for radiotherapy treatment planninga)
Naqa, I. E., Yang, D., Apte, A., Khullar, D., Mutic, S., Zheng, J., Bradley, J. D., Grigsby, P. W., & Deasy, J. O. (2007) · Medical Physics · doi:10.1118/1.2799886 · Cited by 123
Elstrom, R., Leonard, J. P., Coleman, M., & Brown, R. K. J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn282 · Cited by 120
Cooper, K. L., Meng, Y., Harnan, S., Ward, S. E., Fitzgerald, P., Papaioannou, D. E., Wyld, L., Ingram, C., Wilkinson, I. D., & Lorenz, E. (2011) · Health Technology Assessment · doi:10.3310/hta15040 · Cited by 118
Response to Therapy in Breast Cancer
Avril, N. E., Sassen, S., & Roylance, R. R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057240 · Cited by 118
Dooms, C., Verbeken, E., Stroobants, S., Nackaerts, K., Leyn, P. D., & Vansteenkiste, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9550 · Cited by 118
Tomasi, G., Turkheimer, F., & Aboagye, E. O. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0514-2 · Cited by 116
Nakamoto, Y., Zasadny, K., Minn, H., & Wahl, R. (2002) · Molecular Imaging and Biology · doi:10.1016/s1536-1632(01)00004-x · Cited by 115
Role of Positron Emission Tomography in Lymphoma
Juweid, M. E., & Cheson, B. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.904 · Cited by 115
Eigtved, A., Andersson, A. P., Dahlstrøm, K., Rabøl, A., Jensen, M., Holm, S., Sørensen, S. S., Drzewiecki, K. T., Højgaard, L., & Friberg, L. (2000) · European Journal of Nuclear Medicine · doi:10.1007/pl00006666 · Cited by 114
A novel iterative method for lesion delineation and volumetric quantification with FDG PET
van Dalen, J. A., Hoffmann, A. L., Dicken, V., Vogel, W. V., Wiering, B., Ruers, T. J. M., Karssemeijer, N., & Oyen, W. J. G. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328155d154 · Cited by 114
Accuracy of FDG-PET to Diagnose Lung Cancer in a Region of Endemic Granulomatous Disease
Deppen, S. A., Putnam, J. B., Andrade, G. M., Speroff, T., Nesbitt, J. C., Lambright, E. S., Massion, P. P., Walker, R., & Grogan, E. L. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.02.052 · Cited by 113
Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer
de Geus‐Oei, L., van Laarhoven, H. W. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Kamm, Y. J. L., Krabbe, P. F. M., Corstens, F. H. M., Punt, C. J. A., & Oyen, W. J. G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm470 · Cited by 112
Preoperative Diagnosis of Lymph Node Metastases of Colorectal Cancer by FDG-PET/CT
Tsunoda, Y., Ito, M., Fujii, H., Kuwano, H., & Saito, N. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn032 · Cited by 110
Gonzalez-Angulo, A. M., McGuire, S. E., Buchholz, T. A., Tucker, S. L., Kuerer, H. M., Rouzier, R., Kau, S., Huang, E. H., Morandi, P., Ocaña, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.124 · Cited by 110
Iaco, P. D., Musto, A., Orazi, L., Zamagni, C., Rosati, M., Allegri, V., Cacciari, N., AL-NAHHAS, A. M., Rubello, D., Venturoli, S., et al. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.07.013 · Cited by 109
PET/CT of Cancer Patients: Part 1, Pancreatic Neoplasms
Dibble, E. H., Karantanis, D., Mercier, G., Peller, P. J., Kachnic, L. A., & Subramaniam, R. M. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8182 · Cited by 109
Picot, J., Cooper, K., Bryant, J., & Clegg, A. J. (2011) · Health Technology Assessment · doi:10.3310/hta15410 · Cited by 104
Littooij, A. S., Kwee, T. C., Barber, I., Granata, C., Vermoolen, M. A., Enríquez, G., Zsíros, J., Soh, S. Y., de Keizer, B., Beek, F. J. A., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3114-0 · Cited by 102
Qualitative and Quantitative Comparison of PET/CT and PET/MR Imaging in Clinical Practice
Al-Nabhani, K. Z., Syed, R., Michopoulou, S., Alkalbani, J., Afaq, A., Panagiotidis, E., O’Meara, C., Groves, A., Ell, P., & Bomanji, J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123547 · Cited by 101
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon, Y. L., Jones, R. J., & Wahl, R. L. (2007) · PubMed · Cited by 101
Bodet‐Milin, C., Touzeau, C., Leux, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1469-2 · Cited by 99
Cited by
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Zong, W.-X., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,277
Molecular basis of ligand recognition and transport by glucose transporters
Deng, D., Sun, P., Yan, C., Ke, M., Jiang, X., Xiong, L., Ren, W., Hirata, K., Yamamoto, M., Fan, S., et al. (2015) · Nature · doi:10.1038/nature14655 · Cited by 384
Breast cancer detection using deep learning: Datasets, methods, and challenges ahead
din, N. M. U., Dar, R. A., Rasool, M., & Assad, A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106073 · Cited by 363
Functional expression of sodium-glucose transporters in cancer
Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 329
Metadata
- Authors
- Gallamini, A., Zwarthoed, C., & Borra, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2014-09-29
- Volume
- 6
- Issue
- 4
- Pages
- 1821-1889
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2075660225
- Cited by
- 312
- References
- 270
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.